BioDelivery Sciences Files IND for BEMA(TM) LA, a Treatment for Moderate to Severe Pain.
Business Wire › January 06, 2006
Linked as:
Extract
BioDelivery Sciences Files IND for BEMA(TM) LA, a Treatment for Moderate to Severe Pain.
MORRISVILLE, N.C. -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced today that it has submitted an initial Investigational New Drug (IND) Application with the U.S. Food and Drug Administration (FDA) for the company's BEMA(TM) Long Acting Analgesic (LA) pr...
See the full content of this document
Sponsored links
